These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9526541)
1. Vaccine efficacy of recombinant feline herpesvirus type 1 expressing immunogenic proteins of feline calicivirus in cats. Yokoyama N; Maeda K; Fujita K; Ishiguro S; Sagawa T; Mochizuki M; Tohya Y; Mikami T Arch Virol; 1996; 141(12):2339-51. PubMed ID: 9526541 [TBL] [Abstract][Full Text] [Related]
2. Further development of a recombinant feline herpesvirus type 1 vector expressing feline calicivirus immunogenic antigen. Yokoyama N; Fujita K; Damiani A; Sato E; Kurosawa K; Miyazawa T; Ishiguro S; Mochizuki M; Maeda K; Mikami T J Vet Med Sci; 1998 Jun; 60(6):717-23. PubMed ID: 9673943 [TBL] [Abstract][Full Text] [Related]
4. Pathogenicity and vaccine efficacy of a thymidine kinase-deficient mutant of feline herpesvirus type 1 in cats. Yokoyama N; Maeda K; Tohya Y; Kawaguchi Y; Shin YS; Ono M; Ishiguro S; Fujikawa Y; Mikami T Arch Virol; 1996; 141(3-4):481-94. PubMed ID: 8645090 [TBL] [Abstract][Full Text] [Related]
5. Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats. Lappin MR; Andrews J; Simpson D; Jensen WA J Am Vet Med Assoc; 2002 Jan; 220(1):38-42. PubMed ID: 12680445 [TBL] [Abstract][Full Text] [Related]
6. Post-exposure treatment of cats with mouse-cat chimeric antibodies against feline herpesvirus type 1 and feline calicivirus. Umehashi M; Imamura T; Akiyama S; Kimachi K; Tokiyoshi S; Mikami T J Vet Med Sci; 2002 Nov; 64(11):1017-21. PubMed ID: 12499687 [TBL] [Abstract][Full Text] [Related]
7. Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines. Lappin MR; Veir J; Hawley J J Feline Med Surg; 2009 Feb; 11(2):159-62. PubMed ID: 18782676 [TBL] [Abstract][Full Text] [Related]
8. Questions long-term immunity in cats. Norsworthy GD J Am Vet Med Assoc; 1999 Aug; 215(3):316-7. PubMed ID: 10434959 [No Abstract] [Full Text] [Related]
9. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus. Rong S; Lowery D; Floyd-Hawkins K; King V Virus Res; 2014 Aug; 188():60-7. PubMed ID: 24685673 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of serum antibody titers against feline panleukopenia virus, feline herpesvirus 1, and feline calicivirus in cats entering a Florida animal shelter. DiGangi BA; Levy JK; Griffin B; McGorray SP; Dubovi EJ; Dingman PA; Tucker SJ J Am Vet Med Assoc; 2012 Nov; 241(10):1320-5. PubMed ID: 23113524 [TBL] [Abstract][Full Text] [Related]
11. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease. Huang C; Hess J; Gill M; Hustead D J Feline Med Surg; 2010 Feb; 12(2):129-37. PubMed ID: 19836282 [TBL] [Abstract][Full Text] [Related]
12. Questions efficacy of vaccinating cats at 3-year intervals. Norsworthy GD Am J Vet Res; 1999 Aug; 60(8):918-9. PubMed ID: 10451196 [No Abstract] [Full Text] [Related]
14. Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial. Jas D; Frances-Duvert V; Vernes D; Guigal PM; Poulet H Vet Microbiol; 2015 May; 177(1-2):123-31. PubMed ID: 25824128 [TBL] [Abstract][Full Text] [Related]
15. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats. Schwantes A; Truyen U; Weikel J; Weiss C; Löchelt M J Virol; 2003 Jul; 77(14):7830-42. PubMed ID: 12829823 [TBL] [Abstract][Full Text] [Related]
16. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens. Kanellos T; Sutton DJ; Salisbury CF; Chalmers WS J Feline Med Surg; 2008 Aug; 10(4):346-54. PubMed ID: 18448375 [TBL] [Abstract][Full Text] [Related]
17. Potential for broad-spectrum protection against feline calicivirus using an attenuated myxoma virus expressing a chimeric FCV capsid protein. McCabe VJ; Spibey N Vaccine; 2005 Nov; 23(46-47):5380-8. PubMed ID: 16176851 [TBL] [Abstract][Full Text] [Related]
18. Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates. Hohdatsu T; Sato K; Tajima T; Koyama H J Vet Med Sci; 1999 Mar; 61(3):299-301. PubMed ID: 10331208 [TBL] [Abstract][Full Text] [Related]
19. Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan. Ohe K; Sakai S; Takahasi T; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Ishikawa Y; Taneno A Vet Res Commun; 2007 May; 31(4):497-507. PubMed ID: 17225086 [TBL] [Abstract][Full Text] [Related]
20. DNA vaccination against feline calicivirus infection using a plasmid encoding the mature capsid protein. Sommerville LM; Radford AD; Glenn M; Dawson S; Gaskell CJ; Kelly DF; Cripps PJ; Porter CJ; Gaskell RM Vaccine; 2002 Mar; 20(13-14):1787-96. PubMed ID: 11906766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]